These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes. Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075 [TBL] [Abstract][Full Text] [Related]
11. Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation. Sommer CM; Pallwein-Prettner L; Vollherbst DF; Seidel R; Rieder C; Radeleff BA; Kauczor HU; Wacker F; Richter GM; Bücker A; Rodt T; Massmann A; Pereira PL Eur J Radiol; 2017 Jan; 86():143-162. PubMed ID: 28027741 [TBL] [Abstract][Full Text] [Related]
12. A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety. Wang Z; Lu J; Huang W; Wu Z; Gong J; Wang Q; Liu Q; Wang C; Zhu Y; Ding X; Wang Z BMC Cancer; 2021 Feb; 21(1):124. PubMed ID: 33546635 [TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results. Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors. Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Boorjian SA; Carter RE; Geske JR; Callstrom MR; Atwell TD J Urol; 2013 Jan; 189(1):30-5. PubMed ID: 23164375 [TBL] [Abstract][Full Text] [Related]
15. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment. Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230 [TBL] [Abstract][Full Text] [Related]
16. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation. Zhou W; Arellano RS J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298 [TBL] [Abstract][Full Text] [Related]
17. Transarterial embolization of renal cell carcinoma as an adjunctive therapy prior to cryoablation: a propensity score matching analysis. Gunn AJ; Mullenbach BJ; Poundstone MM; Gordetsky JB; Underwood ES; Rais-Bahrami S Diagn Interv Radiol; 2018 Nov; 24(6):357-363. PubMed ID: 30373723 [TBL] [Abstract][Full Text] [Related]
18. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471 [TBL] [Abstract][Full Text] [Related]
19. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients. Zhou W; Herwald SE; Uppot RN; Arellano RS Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1743-1750. PubMed ID: 29721615 [TBL] [Abstract][Full Text] [Related]
20. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes. Kim HJ; Park BK; Park JJ; Kim CK Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]